Aisling Capital II LP

Insider Buys Quantity –
2
2015-04-24SaleEsperion Therapeutics, Inc.
ESPR
10 percent owner
134,938
0.6102%
$106.26$14.34M-74.28%
2015-04-23SaleEsperion Therapeutics, Inc.
ESPR
10 percent owner
300,000
1.338%
$109.10$32.73M-75.18%
2013-10-22PurchaseADMA Biologics, Inc.
ADMA
10 percent owner
823,530
12.6841%
$8.50$7M+0.59%
2013-07-01PurchaseEsperion Therapeutics, Inc.
ESPR
10 percent owner
476,238
3.1033%
$14.00$6.67M+8.67%